Location History:
- University, MS (US) (1993 - 1996)
- Oxford, MS (US) (2007 - 2010)
Company Filing History:
Years Active: 1993-2010
Title: Innovations and Contributions of Jordan K Zjawiony
Introduction
Jordan K Zjawiony is a notable inventor based in University, MS (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with selective opioid receptor affinity. With a total of four patents to his name, Zjawiony's work has implications for both therapeutic applications and research methodologies.
Latest Patents
Zjawiony's latest patents include "Agents with selective κ-opioid receptor affinity," which focuses on compounds and compositions that are derivatives of salvinorin A and salvinorin B. These compounds demonstrate selectivity and potency for the k-opioid receptor (KOR), making them valuable as medicines and chemical probes for radiolabeled binding assays. Another significant patent is the "Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof." This patent outlines enzymatic methods for producing steroid compounds, including 7-dehydropregnenolone and various vitamin D-like compounds, through the action of cytochrome P450scc enzyme on specific substrates.
Career Highlights
Throughout his career, Zjawiony has worked at the University of Mississippi, where he has contributed to various research projects and innovations. His expertise in medicinal chemistry has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Zjawiony has collaborated with notable colleagues, including Alice M Clark and Charles D Hufford. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Jordan K Zjawiony's contributions to medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications and research methodologies.